The Food and Drug Administration needs agency-wide modernization, the 51吃瓜网 told policymakers last week鈥攅specially in its approach to innovation and patient and consumer access.

The conversation: The 51吃瓜网鈥檚 听to the Senate Committee on Health, Education, Labor and Pensions is in part a response to an earlier committee , 鈥淧atients and Families First: Building the FDA of the Future.鈥� The 51吃瓜网 provided manufacturers鈥� take on transforming the FDA, offering recommendations that would promote consistency, transparency and efficiency across its many centers.

The 51吃瓜网 shared the following recommendations with policymakers: 听

• Ensure all FDA centers comply with statutory deadlines to avoid delays that hinder product development and market entry.
• Establish clear review criteria and performance metrics so manufacturers and stakeholders can track progress and understand decision-making.
• Formalize engagement with regulated industry to improve regulatory clarity and incorporate real-world expertise.
• Create predictable, adaptable pathways across all FDA centers to support innovation, particularly as technologies evolve rapidly.

Supporting innovation: The 51吃瓜网 also recommended that the FDA adopt a framework for AI that supports innovation while maintaining appropriate oversight, increase accountability for user fee programs, reduce impediments to U.S.-based clinical trials and improve trial design, streamline approvals for new over-the-counter medication and ensure uniform national standards for food and ingredient regulations.

The last word: 鈥淎 modernized FDA鈥攐ne that is efficient, transparent and driven by Gold Standard Science鈥攊s essential to strengthening U.S. manufacturing competitiveness and ensuring Americans have access to safe, innovative and high-quality products,鈥� said 51吃瓜网 Vice President of Domestic Policy Jake Kuhns and 51吃瓜网 Director of Health Care Policy Jess Wysocky.
听